Weight loss and diet changes in obese patients receiving low-frequency transcutaneous vagal nerve stimulation: results of a randomized placebo-controlled study
https://doi.org/10.15829/1728-8800-2024-4142
EDN: YIFCRB
Abstract
Aim. To assess the changes of body mass index (BMI) and diet in patients with class 1 obesity receiving low-frequency transcutaneous vagal nerve stimulation (tVNS).
Material and methods. This randomized, placebo-controlled study included 88 patients with class 1 obesity and no noncommunicable diseases. The subjects were divided into 2 comparable groups using a random number generator. The patients underwent a comprehensive nutritional analysis using a 24-hour dietary recall and BMI assessment at visit 1 and at a control visit after 6 months of stimulation. Six patients dropped out during the study, and 82 subjects were analyzed over a follow-up period.
Results. In the tVNS group, a significant decrease in BMI was found after 6 months — 33,1 vs 31,6 kg/m2 (p<0,001) compared to placebo — 31,5 vs 31,8 kg/m2 (p<0,819). There was a decrease in the average daily value in the tVNS group after 6 months — 2536,0 vs 1854,0 g/day (p<0,001). The median indicators of total fat, cholesterol and carbohydrates significantly decreased in the tVNS group — 100,8 vs 85,9 g/day (p=0,009), 322,4 vs 195,5 mg/day (p=0,005), 274,4 vs 213,5 mg/day (p=0,001), respectively, compared to placebo — 116,2 vs 91,2 g/day (p=0,791), 357,0 vs 249,5 mg/day (p=0,110), 250,8 vs 196,3 mg/day (p=0,129), respectively.
Conclusion. For the first time, against the background of tVNS, a decrease in BMI, daily calorie intake and consumption of total fat, dietary cholesterol and total carbohydrates was revealed in individuals with class 1 obesity.
Keywords
About the Authors
E. A. RogozhkinaRussian Federation
Moscow
N. S. Karamnova
Russian Federation
Moscow
O. B. Shvabskaya
Russian Federation
Moscow
O. N. Dzhioeva
Russian Federation
Moscow
O. M. Drapkina
Russian Federation
Moscow
References
1. Lobstein T, et al. 2023. World Obesity Atlas 2023, World Obesity Federation. United Kingdom. Retrieved from https://coilink.org/20.500.12592/hrmxx8 on 22 Aug 2024. doi:20.500.12592/hrmxx8.
2. Breit S, Kupferberg A, Rogler G, et al. Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders. Front Psychiatry. 2018;9:44. doi:10.3389/fpsyt.2018.00044.
3. Berthoud HR. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil. 2008;20 Suppl 1(0 1):64-72. doi:10.1111/j.1365-2982.2008.01104.x.
4. Burneo JG, Faught E, Knowlton R, et al. Weight loss associated with vagus nerve stimulation. Neurology. 2002;59(3):463-4. doi:10.1212/wnl.59.3.463.
5. Pardo JV, Sheikh SA, Kuskowsk, MA, et al. Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: An observation. Int J Obes. 2007;31(11):1756-9. doi:10.1038/sj.ijo.0803666.
6. Samniang B, Shinlapawittayatorn K, Chunchai T, et al. Vagus Nerve Stimulation Improves Cardiac Function by Preventing Mitochondrial Dysfunction in Obese-Insulin Resistant Rats. Sci Rep. 2016;6:19749. doi:10.1038/srep19749.
7. Bonaz B, Sinniger V, Pellissier S. The vagus nerve in the neuro-immune axis: implications in the pathology of the gastrointestinal tract. Front Immunol. 2017;8:1452. doi:10.3389/fimmu.2017.01452.
8. Zhang K, Zhou S, Wang C, et al. Acupuncture on Obesity: Clinical Evidence and Possible Neuroendocrine Mechanisms. Evid Based Complement Alternat Med. 2018;2018:6409389. doi:10.1155/2018/6409389.
9. Karamnova NS, Izmailova OV, Kalinina AM, et al. Methodological guide, for the quantitative assessment of the consumed food "Atlas of portions of food and dishes". Moscow: LLC Polygraphy for Business, 2018. p. 110. (In Russ.) ISBN 978-5-600-02141-9.
10. Skurikhin IM, Tutelyan VA. Chemical composition of Russian food products: a reference book. Moscow: DeLi print, 2002. р. 237. (In Russ.) ISBN 5-94343-028-8.
11. Tutelyan VA. Chemical composition and caloric content of Russian food products: a reference book. M.: DeLi plus, 2012. р. 284. (In Russ.) ISBN 978-5-905170-20.
12. Popova AYu, Tutelyan VA, Nikityuk DB. On the new (2021) Norms of physiological requirements in energy and nutrients of various groups of the population of the Russian Federation. Voprosy pitaniia [Problems of Nutrition]. 2021;90(4):6-19. (In Russ.) doi:10.33029/0042-8833-2021-90-4-6-19.
13. Leinen M, Grandy EF, Gebel LMU, et al. Bilateral Subdiaphragmatic Vagal Nerve Stimulation Using a Novel Waveform Decreases Body Weight, Food Consumption, Adiposity, and Activity in Obesity-Prone Rats. Obes Surg. 2024;34(1):1-14. doi:10.1007/s11695-023-06957-w.
14. Loper H, Leinen M, Bassoff L, et al. Both high fat and high carbohydrate diets impair vagus nerve signaling of satiety. Sci Rep. 2021;11(1):10394. doi:10.1038/s41598-021-89465-0.
15. Sobocki J, Królczyk G, Herman RM, et al. Influence of vagal nerve stimulation on food intake and body weight–results of experimental studies. J Physiol Pharmacol. 2005;56(Suppl 6):27-33.
16. Roslin M, Kurian M. The use of electrical stimulation of the vagus nerve to treat morbid obesity. Epilepsy Behav. 2001;2(Suppl): S11-6. doi:10.1006/ebeh.2001.0213.
17. Val-Laillet D, Biraben A, Randuineau G, et al. Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs. Appetite. 2010;55(2):245-52. doi:10.1016/j.appet.2010.06.008.
18. Bodenlos JS, Schneider KL, Oleski J, et al. Vagus nerve stimulation and food intake: effect of body mass index. J Diabetes Sci Technol. 2014;8(3):590-5. doi:10.1177/1932296814525188.
19. Altınkaya Z, Öztürk L, Büyükgüdük İ, et al. Non-invasive vagus nerve stimulation in a hungry state decreases heart rate variability. Physiol Behav. 2023;258:114016. doi:10.1016/j.physbeh.2022.114016.
Supplementary files
What is already known about the subject?
- The prevalence of obesity has almost doubled in recent decades, and today 1/3 of the world's population has obesity and overweight.
- Initial classes of obesity are often not recognized as pathology, since they are not associated with comorbidities. However, an increase in body mass index (BMI) causes an increase in cardiovascular risks, which requires active prevention and novel treatment methods for obesity.
- Vagal nerve stimulation (VNS) helps reduce BMI.
What might this study add?
- For the first time, an assessment of the actual diet of patients with obesity was carried out against the background of low-frequency transcutaneous VNS.
- BMI, average daily value of the diet, total fat, dietary cholesterol and total carbohydrates in patients receiving VNS significantly decreased in comparison with placebo stimulation.
Review
For citations:
Rogozhkina E.A., Karamnova N.S., Shvabskaya O.B., Dzhioeva O.N., Drapkina O.M. Weight loss and diet changes in obese patients receiving low-frequency transcutaneous vagal nerve stimulation: results of a randomized placebo-controlled study. Cardiovascular Therapy and Prevention. 2024;23(10):4142. (In Russ.) https://doi.org/10.15829/1728-8800-2024-4142. EDN: YIFCRB